The controversial abscopal effect: A single-center experience about the combination of stereotactic radiotherapy with pembrolizumab in patients with metastatic dMMR/MSI-H colorectal cancer. DURTRERAD: ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using ...
This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...
Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract ...